Agenda

Since 2015, Mike has been responsible for delivering and further developing Aegon's annual Retirement Readiness Survey and other publications. Mike has also been responsible for the establishment of the Aegon Center for Longevity and Retirement, a collaboration of experts assembled by Aegon with representation from Europe, the Americas, and Asia. The mission of the Center is to conduct research, educate the public and inform a global dialogue on trends, issues and opportunities surrounding longevity, population aging, and retirement security.

Mike has been with Aegon for 17 years where he has previously worked as Sustainability Officer and Group Internal Auditor. Prior to working for Aegon, Mike worked for PwC and Wells Fargo Bank.

Surya Kolluri leads the efforts on Thought Leadership for the Bank of America Retirement and Personal Wealth Solutions Business. In this capacity he oversees research and programs in the areas of Longevity, Retirement and ESG. He manages external relationships including the Stanford Center on Longevity, MIT AgeLab, Wharton Pension Research Council, Boston College Center for Retirement Research and the Gerontological Society of America.

Surya has spoken at a number of public forums including the Tokyo G20 Summit on Aging and Financial Inclusion, White House Conference on Aging Regional Forum in Boston, the National Governors Association summer meeting, the Dementia X forum in Stockholm, the World Health Organization Convening on Healthy Aging in Geneva, the OECD roundtable at Oxford University on the topics of Longevity, Cognitive Decline, Caregiving and Social Impact Investing. He has also engaged with students and researchers on these topics at Harvard, Brown, Yale, Stanford and the University of Pennsylvania.

Surya joined Bank of America in 2006 from Bain & Company. He spent 14 years as a strategy management consultant based out of New York city serving clients in the US and around the world. Surya has an MBA from the Wharton Business School at the University of Pennsylvania and an MS from Drexel University, Philadelphia.

Dr Michael Devoy is the Executive Vice President for Medical Affairs and Pharmacovigilance for the Pharmaceuticals Division at Bayer AG. He is also the Chief Medical Officer of Bayer AG. Dr Devoy joined the former Schering AG in 2005 as Senior Vice President of Global Medical Development and was appointed to his current position in 2014.

Dr Devoy studied Medicine and Pharmacology at University College London and graduated with a Bachelor of Medicine/Bachelor of Surgery (MB, BS). He is a member of the Royal College of Physicians in London. Dr Devoy has extensive experience across Clinical Development and International Medical Affairs. His career in the pharmaceutical industry began when he joined Glaxo Group Research in Clinical Pharmacology.

Irina Kalderon Libal’s career has spanned the European Commission, the UN OHCHR and UNESCO. Her professional areas of focus include active and healthy ageing, health innovation, digital health, and sustainability of health and care systems.

Alana’s academic background spans Podiatric Medicine, Applied Science (Exercise and Sports Science) and Public Health.

Prior to joining WHO, Alana held a range of clinical and managerial positions working on health, disability, rehabilitation and development in Africa, Europe, South Asia, the Middle East and the Western Pacific. After 8 years of leading WHO’s work on disability, Alana joined the Ageing and Life course team in 2014 to lead the development of the World Report on Ageing and Health (2015).

She currently oversees the development of the Decade of Healthy Ageing 2020-2030 and coordinates the organizations work on age-friendly environments including the Global Network on Age-friendly Cities and Communities as well as the Global Campaign to Combat Ageism.

Julie is personally and professionally passionate about tech for healthcare innovation and as a tool to enable healthy aging, and acts on her passion every day in her role at Philips.